MENU
BBOT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BridgeBio Oncology Therapeutics (BBOT) Earnings Date & Reports
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes... Show more
A.I. Advisor
published Earnings
BBOT is expected to report earnings to fall 99.91% to -64 cents per share on November 11
Q3'26
Est.
$-0.65
Q2'26
Missed
by $704.68
Q1'26
Missed
by $0.06
Q4'25
Missed
by $0.07
The last earnings report on August 11 showed earnings per share of -70520 cents, missing the estimate of -51 cents. With 224.21K shares outstanding, the current market capitalization sits at 214.87M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
256 East Grand Avenue
Phone
+1 650 405-4770
Employees
92
Web
https://www.bridgebio.com